Alignment Healthcare, Inc. (ALHC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.24B | 1.01B | 993.7M | 1.02B | 926.93M | 701.24M | 692.43M | 681.29M | 628.6M | 465.39M | 456.71M | 462.38M |
| Revenue Growth % | 33.26% | 44.43% | 43.51% | 49.03% | 47.46% | 50.68% | 51.61% | 47.34% | 43.14% | 28.63% | 26.74% | 26.17% |
| Cost of Goods Sold | - | - | - | - | - | - | - | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 123.31M | 125.67M | 133.55M | 106.03M | 86.34M | 78.99M | 75.97M | 55.38M | 47.63M | 58.83M | 51.73M |
| Gross Margin % | - | 12.18% | 12.65% | 13.15% | 11.44% | 12.31% | 11.41% | 11.15% | 8.81% | 10.23% | 12.88% | 11.19% |
| Gross Profit Growth % | -100% | 42.81% | 59.1% | 75.78% | 91.45% | 81.3% | 34.27% | 46.85% | 29.28% | 33% | 23.86% | -12.62% |
| Operating Expenses | 121.14M | 133.59M | 117.99M | 110.8M | 111.42M | 108.89M | 98.51M | 94.36M | 96.49M | 89.54M | 88.59M | 75.39M |
| OpEx % of Revenue | 9.81% | 13.19% | 11.87% | 10.91% | 12.02% | 15.53% | 14.23% | 13.85% | 15.35% | 19.24% | 19.4% | 16.31% |
| Selling, General & Admin | 121.14M | 0 | 0 | 0 | 0 | 102.13M | 90.87M | 87.86M | 90.51M | 83.74M | 83.09M | 70.2M |
| SG&A % of Revenue | 9.81% | - | - | - | - | 14.56% | 13.12% | 12.9% | 14.4% | 17.99% | 18.19% | 15.18% |
| Research & Development | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 15.5M | -10.28M | 7.68M | 22.75M | -5.39M | -22.55M | -19.52M | -18.38M | -41.11M | -41.91M | -29.76M | -23.66M |
| Operating Margin % | 1.26% | -1.02% | 0.77% | 2.24% | -0.58% | -3.21% | -2.82% | -2.7% | -6.54% | -9.01% | -6.52% | -5.12% |
| Operating Income Growth % | 387.47% | 54.38% | 139.35% | 223.75% | 86.88% | 46.21% | 34.39% | 22.3% | -26.52% | 19.56% | 10.94% | -255.88% |
| EBITDA | 23.34M | -2.45M | 15.67M | 29.78M | 2.23M | -15.74M | -11.84M | -11.84M | -35.08M | -36.05M | -24.2M | -18.39M |
| EBITDA Margin % | 1.89% | -0.24% | 1.58% | 2.93% | 0.24% | -2.24% | -1.71% | -1.74% | -5.58% | -7.75% | -5.3% | -3.98% |
| EBITDA Growth % | 944.85% | 84.43% | 232.36% | 351.49% | 106.37% | 56.35% | 51.08% | 35.62% | -27.52% | 23.87% | 16.27% | -660.44% |
| D&A (Non-Cash Add-back) | 7.84M | 7.83M | 7.99M | 7.04M | 7.63M | 6.81M | 7.69M | 6.54M | 6.03M | 5.86M | 5.56M | 5.26M |
| EBIT | 0 | -10.28M | 7.68M | 22.83M | -5.38M | -25.57M | -19.5M | -18.29M | -41.15M | -41.77M | -29.61M | -23.23M |
| Net Interest Income | 0 | -3.95M | -3.95M | -3.95M | -3.95M | -5.49M | -6.94M | -5.69M | -5.43M | -5.48M | -5.47M | -5.26M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.06M | 3.95M | 3.95M | 3.95M | 3.95M | 5.49M | 6.94M | 5.69M | 5.43M | 5.48M | 5.47M | 5.26M |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | 11.44M | -14.23M | 3.73M | 18.88M | -9.33M | -31.06M | -26.44M | -23.98M | -46.58M | -47.26M | -35.08M | -28.49M |
| Pretax Margin % | 0.93% | -1.41% | 0.38% | 1.86% | -1.01% | -4.43% | -3.82% | -3.52% | -7.41% | -10.15% | -7.68% | -6.16% |
| Income Tax | 25K | -3.23M | 2K | 3.22M | 21K | 7K | -8K | 22K | 0 | -24K | 0 | 1K |
| Effective Tax Rate % | 0.22% | 22.67% | 0.05% | 17.08% | -0.23% | -0.02% | 0.03% | -0.09% | 0% | 0.05% | 0% | -0% |
| Net Income | 11.42M | -11.01M | 3.73M | 15.67M | -9.11M | -31.09M | -26.41M | -24.01M | -46.52M | -47.21M | -35.05M | -28.48M |
| Net Margin % | 0.92% | -1.09% | 0.38% | 1.54% | -0.98% | -4.43% | -3.81% | -3.52% | -7.4% | -10.14% | -7.67% | -6.16% |
| Net Income Growth % | 225.26% | 64.6% | 114.12% | 165.25% | 80.41% | 34.14% | 24.64% | 15.69% | -24.77% | 17.17% | 12.92% | -145.92% |
| Net Income (Continuing) | 11.42M | -11.01M | 3.73M | 15.65M | -9.35M | -31.06M | -26.43M | -24M | -46.58M | -47.23M | -35.08M | -28.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 864K | 1.1M | 1.08M | 1.09M | 1.09M | 1.13M | 1.1M | 1.13M |
| EPS (Diluted) | 0.05 | -0.05 | 0.02 | 0.07 | -0.05 | -0.16 | -0.14 | -0.13 | -0.25 | -0.25 | -0.19 | -0.15 |
| EPS Growth % | 206.16% | 65.75% | 112.71% | 157.54% | 81.16% | 36% | 26.32% | 13.33% | -25% | 19.35% | 13.64% | -150% |
| EPS (Basic) | 0.06 | -0.05 | 0.02 | 0.08 | -0.05 | -0.16 | -0.14 | -0.13 | -0.25 | -0.25 | -0.19 | -0.15 |
| Diluted Shares Outstanding | 213.13M | 200.97M | 208.93M | 209.52M | 193.61M | 191.9M | 191.36M | 190.89M | 189.01M | 188.33M | 187.33M | 185.99M |
| Basic Shares Outstanding | 205.36M | 200.97M | 199.03M | 198.33M | 193.61M | 191.9M | 191.36M | 190.89M | 189.01M | 188.33M | 187.33M | 185.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |